Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Knowles

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Annals of Neurology|January 1, 1991
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosisD S Younger, L P Rowland, N Latov, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cellsJ E Gervasoni, R N Taub, M Rosado, et al.
Neurology|June 1, 1992
Neurolymphomatosis: a clinicopathologic syndrome re-emergesR Diaz-Arrastia, D S Younger, L Hair, et al.
The Annals of Thoracic Surgery|September 1, 1993
Management of lymphoproliferative disorders after cardiac transplantationJ M Chen, M L Barr, A Chadburn, et al.
Blood Cancer Journal|November 11, 2014
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphomaT Zhang, J Ma, K Nie, et al.
Cancer|May 20, 1998
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevantA Chadburn, J M Chen, D T Hsu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 1999
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipientsS D Zangwill, D T Hsu, M R Kichuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2008
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapiesP Martin, A Chadburn, P Christos, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Annals of Neurology|January 1, 1991
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosisD S Younger, L P Rowland, N Latov, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cellsJ E Gervasoni, R N Taub, M Rosado, et al.
Neurology|June 1, 1992
Neurolymphomatosis: a clinicopathologic syndrome re-emergesR Diaz-Arrastia, D S Younger, L Hair, et al.
The Annals of Thoracic Surgery|September 1, 1993
Management of lymphoproliferative disorders after cardiac transplantationJ M Chen, M L Barr, A Chadburn, et al.
Blood Cancer Journal|November 11, 2014
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphomaT Zhang, J Ma, K Nie, et al.
Cancer|May 20, 1998
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevantA Chadburn, J M Chen, D T Hsu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 1999
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipientsS D Zangwill, D T Hsu, M R Kichuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2008
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapiesP Martin, A Chadburn, P Christos, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Pageof 23